跳至主要内容
临床试验/CTRI/2024/01/061877
CTRI/2024/01/061877尚未招募2/3 期

Randomized controlled clinical study to evaluate the effect of Atibala Vati in comparison with Tab Regestrone in management of Asrigdara.

Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Ayurvedic Hospital Rasta Peth1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年1月31日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Patient was diagnosed on the basis of signs and symptoms described in Ayurvedic texts and Modern approach that is subjective and objective criteria

研究概览

简要总结

The word Asrugdara got its defination as dirana ( excessive secretion and excretion ) asrig (Menstrual blood)

Asrugdara is a condition of excessive or prolonged uterine bleeding which is accompanied wiyh or without menstruation.

Atibala has madhur snighda sheeta virya and also one of the content of balya gana

Thus it will not only act on doshas but will also help in subsiding the upadrava and symptoms of Raktapradar.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1.Increased number of bleeding days that is more than 7 days
  • Quantitative increase in Menstrual blood that is more than 80 ml or more than 3 pads per day.
  • Decreased Intermenstrual period that is less than 21 days.

排除标准

  • Traumatic bleeding
  • Post menopausal bleeding
  • Cervical uterine ovarian Neoplasm
  • Endometriosis.
  • 6.Bleeding through Gravid uterus
  • cerical polyp and erosion
  • Coagulopathy.

结局指标

主要结局

Patient was diagnosed on the basis of signs and symptoms described in Ayurvedic texts and Modern approach that is subjective and objective criteria

时间窗: 3 6 10 days

Subjective Criteria

时间窗: 3 6 10 days

1. Duration of bleeding in days

时间窗: 3 6 10 days

2. Quantity of blood loss

时间窗: 3 6 10 days

次要结局

  • objective criteria(1. USG ET before and after)

研究者

发起方
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Ayurvedic Hospital Rasta Peth
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Mansi Sarvade

Tilak Ayurved Mahavidyalaya, Pune

研究点 (1)

Loading locations...

相似试验